Ignite Creation Date:
2025-12-24 @ 2:39 PM
Ignite Modification Date:
2026-01-14 @ 3:39 PM
Study NCT ID:
NCT06854159
Status:
RECRUITING
Last Update Posted:
2025-09-29
First Post:
2025-02-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Sponsor:
Organization: